Report of Foreign Issuer (6-k)
06 Agosto 2019 - 5:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
Report of
Foreign Private Issuer
Pursuant to Rule
13a-16
or
15d-16
under the Securities Exchange Act of 1934
Date of Report: August 6, 2019
Commission File Number:
001-36891
Cellectis S.A.
(Exact
Name of registrant as specified in its charter)
8, rue de la
Croix Jarry
75013 Paris, France
+33 1 81 69 16 00
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form
20-F
or Form
40-F:
Form 20-F ☒
Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(7): ☐
Exhibits
The following document, which is attached as an exhibit hereto, is incorporated by reference herein.
This report on Form
6-K
shall be deemed to be incorporated by reference in the registration statements of Cellectis
S.A. on Form
F-3
(No.
333-217086)
and Form
S-8
(Nos.
333-204205,
333-214884,
333-222482
and
333-227717),
to the extent not superseded by documents or reports subsequently filed.
|
|
|
Exhibit
|
|
Title
|
|
|
99.1
|
|
Cellectis S.A.s interim report for the three-month and
six-month
periods ended June 30, 2019.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELLECTIS S.A.
(Registrant)
|
|
|
|
|
August 6, 2019
|
|
|
|
By:
|
|
/s/ André Choulika
|
|
|
|
|
|
|
André Choulika
|
|
|
|
|
|
|
Chief Executive Officer
|
Cellectis (PK) (USOTC:CMVLF)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Cellectis (PK) (USOTC:CMVLF)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
Notícias em tempo-real sobre Cellectis (PK) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Cellectis S.a.